← Open Payments lookup

LANCE STEIN: Open Payments

NPI 1568558062 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$314,704 in 271 payments from 22 companies in 2025. Trend: 2023 $73,693 · 2024 $191,860 · 2025 $314,704

Speaker / faculty: $281,600Consulting: $17,324Travel & lodging: $8,934Food & beverage: $6,846
CompanyPaymentsAmount
Madrigal Pharmaceuticals87$136,878
Ipsen Biopharmaceuticals, Inc45$75,188
Mallinckrodt Hospital Products Inc.32$60,493
Gilead Sciences, Inc.38$22,205
ABBVIE INC.13$14,685
Bausch Health US, LLC1$2,188
Intercept Pharmaceuticals, Inc.13$1,467
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$729
Novo Nordisk Inc6$254
Fujifilm Healthcare Americas Corporation1$125

Products named: REZDIFFRA, TERLIVAZ, IQIRVO, Livdelzi, Bylvay, MAVYRET, OCALIVA, XIFAXAN.

Industry payments across GA — which companies pay providers there.